Life Sciences

Oerth’s unique PROTAC® protein degradation technology is expected to be a new, game-changing generation of more sustainable crop protection products /…

Pathalys Pharma, the Research Triangle Park-based biopharmaceutical company developing therapies for end-stage kidney disease, has secured $150 million in new…

Mazen Animal Health, an Iowa start-up company that’s developing corn-based oral vaccines for animals, has selected North Carolina as the…

Novo Nordisk has gifted $6 million to Durham Technical Community College in an effort to boost the institution’s life sciences…

Fayaz Khazi, Ph.D. – formerly CEO of North Carolina-based food and agricultural enterprise Elo Life Systems – has launched a…

In 2021, a group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell…

Two companies – Oerth Bio of Durham and Yara International of Norway – are teaming up to promote technology they believe will help farmers…

The North Carolina Biotechnology Center awarded 23 grants and loans totaling over $1.4 million to bioscience companies, universities and nonprofit…

Researchers at Duke are Creating More Precise Approaches to Stopping Tumors For decades, medical cancer treatment has generally meant chemotherapy,…